research Subcision: A Further Modification, an Ever Continuing Process
New subcision technique with a bent needle and syringe improves ease, effectiveness, and comfort for treating acne scars.
Search
forResearch
5 / 1000+ results research Optimizing Post‐Acne Scar Treatment: A Pilot Comparative Study of Endo‐Radiofrequency Subcision With and Without Platelet‐Rich Plasma
Combining Endo-RF with PRP may improve acne scars better than Endo-RF alone.
research Subcision with Blunt Cannula in Combination with Injection of PRP and Microneedling in Treatment of Acne Scar
Combining subcision, PRP, and microneedling effectively treats acne scars with minimal side effects.
research 54481 A Comparative Analysis of CO2 Laser Therapy, RF Microneedling, TCA Cross, and Subcision on Post-Acne Boxcar Scarring in Skin of Color
Subcision is the most efficient, cost-effective, and safest treatment for post-acne boxcar scarring in skin of color.
research Combination treatment for acne scars Subcision with blunt cannula, platelet-rich plasma injections, and microneedling
The combination treatment improved acne scars.
Community Join
3 / 1000+ resultscommunity Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years
The conversation is about a new acne treatment cream called Clascoterone Cream 1%, which is the first new mechanism of action for acne in nearly 40 years. One person joked about hoping their face will be as clean as their bald head after using the cream.
community Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
Veradermics' extended-release oral minoxidil is expected to be commercially available in 2027-2028, while another company, Minx, may release a similar product sooner. VDPHL01 is considered more clinically validated compared to Minx.
community Breezula 6 Month Topline Phase III Results Released
Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.
Learn
— no results
Experts
— no results
Clinics
— no results